Longwall Venture Partners is a specialist venture capital firm focused on backing early-stage UK companies operating in the healthcare, science, and engineering sectors.
Portfolio
10
companies
Caristo Diagnostics
Caristo Diagnostics develops AI-assisted tools for cardiac and vascular disease diagnostics.
Closed Loop Medicine
Closed Loop Medicine develops integrated drug and digital therapeutics to enable precision dosing.
Helio Display Materials
Helio Display Materials creates proprietary perovskite materials to improve screen performance and energy efficiency.
Keit
Keit manufactures robust spectrometer technology for industrial process monitoring.
Kinomica
Kinomica develops proteomic data science platforms to advance precision cancer treatments.
LettUs Grow
LettUs Grow builds indoor farming technology and management software for sustainable agriculture.
Lightcast Discovery
Lightcast Discovery builds a novel single-cell functional analysis platform for life science research.
MicrofluidX
MicrofluidX provides next-generation bioreactors for cell research and manufacturing.
UroSens
UroSens develops diagnostic immunoassays to detect prostate and bladder cancer.
Wayland Additive
Wayland Additive develops advanced electron beam 3D printing systems for industrial manufacturing.
Rebecca Todd
Investment Director
Rebecca brings venture capital experience as a partner at Longwall Venture Partners, alongside non-executive roles across several portfolio companies.
LinkedInDavid Denny
Partner
M Ventures led the Series B round to support the company ahead of its commercial launch.
"The power of single-cell analysis to uncover the complexities of biology has become increasingly evident, but much of the work still focuses on the transcriptome as the primary readout."
The financing round was led by Oxford Science Enterprises and will support market expansion in the UK, EU, and United States.
"We are thrilled that five successful institutional investors participated in the financing round which validates the vast clinical and business potential of Caristo’s innovations"
The Stevenage enterprise raised the capital from Longwall Ventures and a syndicate of backers to fund trials and product development.
"Advanced therapy manufacturing is hindered by out of date, inadequate manufacturing technologies,"
The funding round was led by Longwall Venture Partners and BGF to drive team expansion and new laboratory facilities.
"Helio is on a mission to use our world-leading perovskite science to step up the performance and efficiency of displays. This fund raising marks a change of gear for Helio, enabling us to significantly grow our capacity to design products and engage with partners in the display supply chain. I would like to thank and acknowledge our enormously supportive investors who share our vision of a bright future for perovskites in displays."
The financing round was co-led by Ananda Impact Ventures and BGF to accelerate platform and product development.
